BIORESTORATIVE THERAPIES, INC. Liabilities Subject to Compromise, Debt and Accrued Interest
BIORESTORATIVE THERAPIES, INC. (BRTX) had Liabilities Subject to Compromise, Debt and Accrued Interest of $1.03 million as of 2020-09-30, per its 10-Q filed 2021-04-12.
Discontinued › Notes › Reorganizations › Liabilities Subject to Compromise
us-gaap:LiabilitiesSubjectToCompromiseDebtAndAccruedInterest · last filed 2021-04-12
- 2020-09-30: Liabilities Subject to Compromise, Debt and Accrued Interest $1.03M.
- 2020-06-30: Liabilities Subject to Compromise, Debt and Accrued Interest $1.03M.
| Period end | Liabilities Subject to Compromise, Debt and Accrued Interest |
|---|---|
| 2020-09-30 | $1.03M 10-Q · filed 2021-04-12 |
| 2020-06-30 | $1.03M 10-Q · filed 2021-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |